Table 3.
Laboratory values, vital signs, and antithrombic medication use with hemoptysis severity
| Entire Sample | Mild-Moderate | Severe | OR (95% C.I.) | p-value a | |
|---|---|---|---|---|---|
| N = 229 | N = 200 | N = 29 | |||
| Laboratory values b | Median (IQR) | Median (IQR) | Median (IQR) | ||
| Hemoglobin g/dL | 12.9 (11.1, 13.9) | 13.0 (11.2, 13.9) | 12.5 (10.9, 14.0) | 0.94 (0.77 – 1.14) | .53 |
| Hematocrit g/dL | 39.3 (34.7, 41.7) | 39.3 (34.8, 41.7) | 38.6 (32.2, 42.4) | 0.98 (0.92 – 1.06) | .63 |
| Platelet (X103 microL) | 225.0 (178, 283) | 225.0 (179, 283) | 212.0 (154, 289) | 1.03 (0.99 – 1.06) | .14 |
| INR | 1.1 (0.9, 1.1) | 1.0 (0.9, 1.2) | 1.1 (0.9, 1.2) | 1.00 (0.99 – 1.01) | .81 |
| n (%) | n (%) | n (%) | |||
| Platelet Category (p=.951) | |||||
| < 50,000 | 6 (2.6) | 5 (2.5) | 1 (3.4) | ----- | ----- |
| 50 – 100,000 | 7 (3.1) | 6 (3.0) | 1 (3.4) | ----- | ----- |
| > 100,000 | 216 (94.3) | 189 (94.5) | 27 (93.1) | ----- | ----- |
| N=199 | |||||
| Baseline vital signs | Median (IQR) | Median (IQR) | Median (IQR) | ||
| Heart rate (bpm) | 75.5 (66, 85) | 75.0 (66, 86) | 78.0 (65, 85) | 1.00 (0.97 – 1.03) | .97 |
| Systolic BP (mmHg) | 148.0 (125, 169) | 148.0 (125, 169) | 151.0 (130, 171) | 1.00 (0.98 – 1.02) | .89 |
| Oxygen saturation (%) | 97.0 (96, 97) | 97.0 (96, 98) | 97.0 (96, 99) | 1.13 (0.91 – 1.40) | .26 |
| n (%) | n (%) | n (%) | |||
| Systolic BP > 190 mmHg | 14 (6.1) | 13 (6.5) | 1 (3.4) | ----- | ----- |
| Aspirin use pre-procedure | 81 (35.4) | 67 (33.5) | 14 (48.3) | 1.85 (0.84 – 4.07) | .12 |
| If ASA used, held (p = .007) | N=75 | N=63 | N=12 | ||
| >= 5 days | 52 (69.3) | 48 (76.2) | 4 (33.3) | ----- | ----- |
| 2–4 days | 10 (13.3) | 5 (7.9) | 5 (41.7) | ----- | ----- |
| <= 1 day | 13 (17.3) | 10 (15.9) | 3 (25.0) | ----- | ----- |
| N = 229 | N = 200 | N = 29 | |||
| Non-ASA antithrombotic use | 50 (21.8) | 43 (21.5) | 7 (24.1) | 1.16 (0.46 – 2.91) | .75 |
| If non-ASA used, held (p= .47) | N=49 | N=43 | N=6 | ||
| Per department protocol | 47 (95.9) | 41 (95.3) | 6 (100.0) | ----- | ----- |
| Not per department protocol | 2 (4.2) | 2 (4.7) | 0 (0.0) | ----- | ----- |
a
Specific contrast, Likelihood Ratio Chi-Square
b
Laboratory values obtained within month proceeding PTNB